Conference Coverage
Novel BioFreedom coronary stent looks promising
Key clinical point: A novel coronary stent combines the antirestenotic benefits of a drug-eluting stent with the safety of a bare metal stent.
LEADERS FREE was underwritten by Biosensors International, maker of the BioFreedom stent. Dr. Urban and several of his coinvestigators disclosed relationships with device makers, including Edward Lifesciences, Terumo, Abbott Vascular, and Quest Medical.
On Twitter @whitneymcknight